About
Bonito Biosciences develops a platform technology for programmable oligonucleotide delivery, employing encoded libraries and AI to discover targeted delivery ligands for RNA degraders and other therapeutic modalities.
Explore Bonito Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.